Titan Medical President and CEO Cary Vance said he knew what he was getting into when he was approached about leading the robotic surgery company. “The challenges, I knew what they were,” said Vance, who had served on the company’s board for two years when he became CEO of Titan in July. “I knew the opportunity we […]

Among patients with advanced and/or metastatic hormone receptor–positive HER-2 negative breast cancer, complete estrogen receptor antagonist OP-1250 continued to yield clinical benefits such as reductions in target tumor lesions. OP-1250, an estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD), has continued to produce strong anti-tumor activity among patients with advanced and/or metastatic ER-positive, […]

Last year, Roche and Genentech paid $50 million for licensing rights to Lineage Cell Therapeutics’ OpRegen program, a cell therapy that looks to regenerate healthy versions of retinal pigment epithelial cells in patients’ eyes. Now the biotech is growing its physical presence with a new facility in the US and an expansion in Israel.